期刊文献+

晚期非小细胞肺癌血清游离DNA水平变化及意义 被引量:4

Changes in the levels of serum free DNA in patients with ⅢB /Ⅳ stage non-small-cell lung cancer
下载PDF
导出
摘要 目的探讨ⅢB/Ⅳ期非小细胞肺癌(NSCLC)患者血清游离DNA的水平变化及其临床意义。方法采用荧光定量PCR方法检测60例NSCLC患者和30例健康人外周血清中游离DNA水平,并结合其临床特征统计分析。结果ⅢB期/Ⅳ期NSCLC患者和健康人群血清游离DNA值分别为(218.67±95.73)ng/mL与(11.30±3.80)ng/mL(P<0.001)。ⅢB期与Ⅳ期NSCLC患者血清游离DNA水平分别为(157.10±53.50)ng/mL与(255.88±93.28)ng/mL(P<0.05)。腺癌患者血清游离DNA水平明显高于鳞癌患者(P<0.05)。结论ⅢB/Ⅳ期NSCLC患者血清游离DNA水平升高,且以Ⅳ期患者为著。血清游离DNA水平可能成为NSCLC早期诊断和临床分期的重要指标。 Objective To investigate the levels of serum free DNA and its clinical significance in patients with ⅢB /Ⅳ stage non-small-cell lung cancer( NSCLC). Methods The levels of serum free DNA in 60 patients with NSCLC and30 healthy counterparts served as controls were detected by using fluorescent quantitative PCR,and were analyzed with relation to the clinical features. Results The serum level of free DNA was( 218. 67 ± 95. 73) ng / mL in IIIB / IV stage NSCLC patients and( 11. 30 ± 3. 80) ng / mL in controls. There was a positive correlation between the serum level of free DNA and clinical staging of NSCLC( 157. 10 ± 53. 50 ng / mL for ⅢB and 255. 88 ± 93. 28 ng / mL for Ⅳ stage,F = 2. 020,P < 0. 05). Free DNA level in patients with adenocarcinoma was significantly higher than that in patients with squamous cell carcinoma( P < 0. 05). Conclusion The serum level of free DNA in ⅢB / Ⅳ stage patients is increased,obviously inⅣ stage. The serum level of free DNA may become an important indicator in early diagnosis and TNM stage of NSCLC.
出处 《山东医药》 CAS 2013年第30期6-8,共3页 Shandong Medical Journal
基金 "十一五"军队中医药重大临床攻关课题资助项目(2006051002)
关键词 非小细胞肺癌 游离DNA non-small-cell lung carcinoma free DNA
  • 相关文献

参考文献4

二级参考文献14

  • 1屠红,高海峰,傅士龙,陈颢.肿瘤患者循环DNA的定量研究[J].中华肿瘤杂志,2004,26(10):606-608. 被引量:8
  • 2杨顺芳,董强刚,张佩玲,曹杰,曾骏,井口东郎.肺癌患者血清中游离DNA含量与肿瘤标志物相关性分析[J].标记免疫分析与临床,2006,13(1):7-10. 被引量:3
  • 3LEON S A,SHAPIRO B,SKLAROFF D M,et al. Free DNA in the serum of cancer patients and the effect of the therapy [ J ]. Cancer Res, 1977,37:646-650.
  • 4SOZZI G,CONTE D,MARLANI L,et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung patients [ J ]. Cancer Res,2001,61 (12) :4675-4678.
  • 5SANCHEZ-CESPEDES M, ESTELLER M, WU L,et al. Crene promoter hypermethylation in tumor and serum of head and neck cancer patients[ J ]. Cancer Res,2000,60 (4) : 892-895.
  • 6HIBI K, ROBINSON R, BOOKER S, et al. Molecular detection of gengtic alteration in the serum of colorectal cancer patients[ J]. Cancer Res, 1998,58 ( 7 ) : 1405-1407.
  • 7Herman JG,Graff JR,Myohanen S,et al.Methylaiton-Specific PCR: a novel PCR assay for methylation status of CpG islands[].Proceedings of the National Academy of Sciences of the United States of America.1996
  • 8Jahr S,Hentze H,Englisch S,et al.DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells[].Cancer Research.2001
  • 9Anker P,Lefort F,Vasioukhin V,et al.K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer[].Gastroenterology.1997
  • 10Mulcahy HE,Lyautey J,Lederrey C,et al.A prospective study of K-ras mutations in the plasma of pancreatic cancer patients[].Clinical Cancer Research.1998

共引文献147

同被引文献40

  • 1杨顺芳,董强刚,张佩玲,曹杰,曾骏,井口东郎.肺癌患者血清中游离DNA含量与肿瘤标志物相关性分析[J].标记免疫分析与临床,2006,13(1):7-10. 被引量:3
  • 2张弦,唐立.非小细胞肺癌患者血中DNA片段的检测、定量及临床意义的研究[J].中国微生态学杂志,2007,19(6):516-518. 被引量:5
  • 3Diaz LA Jr,Bardelli A.Liquid Biopsies:Genotyping circulating tumor DNA[J].J Clin Oncol,2014,32(6):579-586.
  • 4Widschwendter M,Menon U.Circulating methylated DNA:A new generation of tumor markers[J].Clin Cancer Res,2006,12 (24):7205-7208.
  • 5Sonobe M,Tanaka F,Wada H.Lung cancer-related genes in the blood[J].Ann Thorac Cardiovasc Surg,2004,10 (4):213-217.
  • 6Nakamura T,Sueoka-Aragane N,Iwanaga K,et al.A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA[J].J Thorac Oncol,2011,6(10):1639-1648.
  • 7Liu XQ,Lu YC,Zhu GS,et al.The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer:comparison of methodologies[J].J Clin Pathol,2013,66:12 1065-1069.
  • 8Jahr S,Hentze H,Englsch S,et al.DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells[J].Cancer Res,2001,61 (4):1659-1665.
  • 9García-Olmo DC,Domínguez C,García-Arranz M,et al.Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells[J].Cancer Res,2010,70(2):560-567.
  • 10Szpechcinski A,Dancewicz M,Kopinski P,et al.Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls[J].Eur J Med Res,2009,14 (Suppl 4):237-240.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部